The Deal Register
Database › Equity financing › BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M

Equity financing

BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M

Lane
Equity financing
Announced
30 Oct 2025
Province
British Columbia
Industry
Unclassified
Status
Announced
What the filing says
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (" BioVaxys " or the " Company ") announces an increase to its non-brokered private placement financing (the " Offering ") previously announced on October 7, 2025.
Terms stated
price per security
Releases (2)
  • 07 Oct 2025 — BIOVAXYS ANNOUNCES LIFE OFFERING
  • 30 Oct 2025 — BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
Source

The terms are in the subscriber edition

This transaction carries 1 stated term, with its value, unit and basis and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe